These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9676925)

  • 1. The use of medical and social history as prescreening to eliminate cornea donors at risk of having hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV).
    Davis AR
    Cornea; 1998 Jul; 17(4):457-8. PubMed ID: 9676925
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence of positive hepatitis B, hepatitis C, and HIV serology in cornea donors prescreened by medical and social history in Ontario, Canada.
    Armstrong SA; Gangam N; Chipman ML; Rootman DS
    Cornea; 1997 Sep; 16(5):512-6. PubMed ID: 9294680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor high-risk social behaviors on recipient survival in cardiac transplantation.
    Xu DS; Hartman D; Ludrosky K; Campbell J; Starling RC; Taylor DO; Smedira NG; Gonzalez-Stawinski GV
    Transplantation; 2010 Apr; 89(7):873-8. PubMed ID: 20090571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nosocomial hepatitis B virus, hepatitis C virus and HIV infections by infectious medial personnel].
    Hasselhorn HM; Hofmann F
    Gesundheitswesen; 1998 Oct; 60(10):545-51. PubMed ID: 9844287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grafting and the risk of hepatitis transmission: is there reason to be cautious? Are we cautious enough?
    Sugar J; Mannis M
    Cornea; 1997 Mar; 16(2):123-4. PubMed ID: 9071522
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among eye donors.
    Mahalakshmi B; Madhavan HN; Pushpalatha R; Margarita S
    Indian J Ophthalmol; 2004 Mar; 52(1):61-2. PubMed ID: 15132383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA; Kotila TR; Akinyemi JO
    Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV, HBV and HCV: new developments related to transfusion safety.
    Busch MP
    Vox Sang; 2000; 78 Suppl 2():253-6. PubMed ID: 10938963
    [No Abstract]   [Full Text] [Related]  

  • 18. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology.
    Delwart E; Kuhns MC; Busch MP
    J Med Virol; 2006; 78 Suppl 1():S30-5. PubMed ID: 16622875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amniocentesis and viral risk (hepatitis B, C virus and HIV)].
    Ducarme G; Ceccaldi PF; Bernuau J; Luton D
    J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):469-73. PubMed ID: 19679409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.
    Tripathi AK; Khanna M; Gupta N; Chandra M
    J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.